Last updated on January 2019

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

Brief description of study

The study is designed to test the hypothesis that patients with Locally advanced rectal cancer ( LARC) treated with Total neoadjuvant therapy (TNT) and Total mesorectal excision (TME) or Non-operative management (NOM) will have an improved 3-year disease-free survival (DFS) compared to patients with similar tumors treated with Chemoradiation therapy (CRT), Total mesorectal excision (TME) and Adjuvant chemotherapy (ACT).

Clinical Study Identifier: NCT02008656

Contact Investigators or Research Sites near you

Start Over

St. Joseph Hospital

Orange, CA United States
  Connect »

John Muir Health

Walnut Creek, CA United States
  Connect »

University of Colorado

Aurora, CO United States
  Connect »

Cleveland Clinic Florida

Weston, FL United States
  Connect »

University of Chicago

Chicago, IL United States
  Connect »

University of Michigan

Northville, MI United States
  Connect »

CHI Heath Bergan Mercy

Omaha, NE United States
  Connect »

Cleveland Clinic

Cleveland, OH United States
  Connect »

University of Virginia

Charlottesville, VA United States
  Connect »

Washington Hospital Center

Washington, WA United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.